Masahiro Torasawa

Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients.

Y. Ohe, N. Yamamoto, S. Murakami, 2022, Clinical lung cancer.

Anaphylaxis to three humanized antibodies for severe asthma: a case study

Kazuhisa Takahashi, N. Harada, J. Ito, 2020, Allergy, Asthma & Clinical Immunology.